Atlas Trials

Platin-based Chemotherapeutics to Enhance Dendritic Cell Vaccine Efficacy in Melanoma Patients

Clinical trial NCT02285413 · COMPLETED

Trial details

NCT number
NCT02285413
Sponsor
Radboud University Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Melanoma
Start date
2011-02-01
Primary completion
2015-10-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.